Actively Recruiting
Effect of Strontium-90 Brachytherapy Combined With Hyperthermia in the Treatment of Keloid
Led by Nanjing First Hospital, Nanjing Medical University · Updated on 2024-05-28
80
Participants Needed
2
Research Sites
58 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Keloid patients were randomized into the experimental and control groups. Experimental group: Strontium-90 (Sr-90) brachytherapy followed by hyperthermia. Control group: Sr-90 brachytherapy alone .
CONDITIONS
Official Title
Effect of Strontium-90 Brachytherapy Combined With Hyperthermia in the Treatment of Keloid
Who Can Participate
Eligibility Criteria
You may qualify if you...
- The patient was clinically diagnosed with keloid, and the keloid area was clean without rupture and exudation
- Body surface keloid thickness: 2~5mm
- Diameter of keloid 210mm
- Age between 16 and 75 years
You will not qualify if you...
- Women who plan to become pregnant within 3 months or are pregnant or breastfeeding
- Patients with cicatricial constitution
- Abnormal coagulation function
- Patients who have received an adequate dose or course of radiation therapy
- People with previous immune system diseases, diabetes and other metabolic diseases
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Nanjing First Hospital
Nanjing, Jiangsu, China, 210006
Actively Recruiting
2
The First Affiliated Hospital of Nanjing Medical Univerity
Nanjing, Jiangsu, China, 210006
Actively Recruiting
Research Team
F
Feng Wang
CONTACT
L
Liang Shi
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here